Is sentinel node biopsy the standard of care in melanoma management? the opinions and practices of Australian specialists

Australasian Journal of Dermatology

Volumn 53, Issue 2, 2012, Pages 93-97

  Anderson, Austen ^a   Love, Robert ^a   Chan, Jonathan ^a  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

melanoma; MSLT 1; sentinel node biopsy; standard of care

Indexed keywords

ARTICLE; AUSTRALIA; DERMATOLOGIST; HEALTH CARE SURVEY; HUMAN; MEDICAL EXPERT; MEDICAL PRACTICE; MELANOMA; ONLINE MONITORING; PATIENT CARE; PATIENT COUNSELING; PLASTIC SURGEON; SENTINEL LYMPH NODE BIOPSY; STANDARD;

ATTITUDE OF HEALTH PERSONNEL; AUSTRALIA; DATA COLLECTION; DERMATOLOGY; HUMANS; MELANOMA; PHYSICIAN'S PRACTICE PATTERNS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURGERY, PLASTIC;

EID: 84861094379     PISSN: 00048380     EISSN: 14400960     Source Type: Journal    
DOI: 10.1111/j.1440-0960.2012.00889.x     Document Type: Article

References (23)

1. Parkin DM, Bray F, Ferlay J, et al,. Global cancer statistics, 2002. CA Cancer J. Clin. 2005; 55: 74-108. (Pubitemid 40372904)
2. Australian Institute of Health and Welfare (AIHW). ACIM (Australian Cancer Incidence and Mortality) Books. Canberra: AIHW, 2010.
3. Balch CM, Buzaid AC, Soong SJ, et al,. Final version of the American Joint Committee on cancer staging system for cutaneous melanoma. J. Clin. Oncol. 2001; 19: 3635-48. (Pubitemid 32786276)
4. Balch CM, Cascinelli N,. Sentinel-node biopsy in melanoma. N. Engl. J. Med. 2007; 356: 419-21.
5. Thomas JM,. Concerns relating to the conduct and statistical analysis of the multicenter selective lymphadenectomy trial (MSLT-1) in patients with melanoma. J. Plast. Reconstr. Aesthet. Surg. 2009; 62: 442-6.
6. Phan GQ, Messina JL, Sondak VK, et al,. Sentinel node biopsy for melanoma: indications and rationale. Cancer Control. 2009; 16: 234-9.
7. Ross MI, Gershenwald JE,. How should we view the results of the multicentre selective lymphadenectomy trial-1 (MSLT-1)? Ann. Surg. Oncol. 2008; 15: 670-3.
8. Rosenberg SA,. Why perform sentinel-lymph-node-biopsy in patients with melanoma? Nat. Clin. Pract. Oncol. 2008; 5: 1. (Pubitemid 351512418)
9. Stebbins WG, Garibyan L, Sober AJ,. Sentinel node biopsy and melanoma: 2010 update, Part I. J. Am. Acad. Dermatol. 2010; 62: 723-34.
10. Essner R,. Sentinel lymph node biopsy and melanoma biology. Clin. Cancer Res. 2006; 12 (7 Suppl): 2320s-5s.
11. Ling A, Dawkins R, Bailey M, et al,. Short-term morbidity associated with sentinel lymph node biopsy in cutaneous malignant melanoma. Australas. J. Dermatol. 2010; 51: 13-17.
12. Morton DL, Cochran AJ, Thompson JF, et al,. Sentinel node biopsy for early stage melanoma- accuracy and morbidity in MSLT-1, an international multicentre trial. Ann. Surg. 2005; 242: 302-13. (Pubitemid 41306595)
13. Karim RZ, Scolyer RA, Li W, et al,. False negative sentinel lymph node biopsies in melanoma may result from deficiencies in nuclear medicine, surgery or pathology. Ann. Surg. 2008; 247: 1003-10. (Pubitemid 351770421)
14. Morton DL, Thompson JF, Cochran AJ, et al,. Sentinel-node biopsy or nodal observation in melanoma. N. Engl. J. Med. 2006; 355: 1307-17. (Pubitemid 44465459)
15. Cadili A, Dabbs K,. Predictors of sentinel lymph node metastasis in melanoma. Can. J. Surg. 2010; 53: 32-6.
16. Balch CM, Morton DL, Gershenwald JE, et al,. Sentinel node biopsy and standard of care for melanoma. J. Am. Acad. Dermatol. 2009; 60: 872-5.
17. Kanzler MH,. Sentinel node biopsy and standard of care for melanoma: a re-evaluation of the evidence. J. Am. Acad. Dermatol. 2011; 62: 880-4.
18. Balch CM, Soong SJ, Gershenwald JE, et al,. Prognostic factors analysis of 17, 600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J. Clin. Oncol. 2001; 19: 3622-34. (Pubitemid 32786275)
19. Gershenwald JE, Thompson W, Mansfield PF, et al,. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel node status in 612 stage I or stage II melanoma patients. J. Clin. Oncol. 1999; 17: 976-83. (Pubitemid 29109331)
20. McMasters KM, Chao C, Wong SL, et al,. Interval sentinel lymph nodes in melanoma. Arch. Surg. 2002; 137: 543-7.
21. Australian Cancer Network Melanoma Guidelines Revision Working Party. Clinical Practice Guidelines for the Management of Melanoma in Australia and New Zealand. Sydney: Cancer Council Australia and Australian Cancer Network (and Wellington: New Zealand Guidelines Group), 2008.
22. Stebbins WG, Garibyan L, Sober AJ,. Sentinel lymph node biopsy and melanoma: 2010 update part II. J. Am. Acad. Dermatol. 2010; 62: 737-48.
23. Agnese DM, Abdessalam SF, Burak WE, et al,. Cost-effectiveness of sentinel lymph node biopsy in thin melanomas. Surgery 2003; 134: 542-7.